Ultime notizie per Addex Therapeutics (NASDAQ:ADXN) Azioni

Addex Therapeutics

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics Ltd

Gartner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Gartner, presenting an average target of $508.0, a high estimate of $605.00, and a low estimate of $401.00. A decline of 8.93% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1745272862_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A clear picture of Gartner's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Manav Patnaik &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $475.00&#x7C;$510.00 &#x7C; 
&#x7C;Jason Haas &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Underweight &#x7C; $401.00&#x7C;$488.00 &#x7C; 
&#x7C;Manav Patnaik &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $510.00&#x7C;$600.00 &#x7C; 
&#x7C;Joshua Chan &#x7C;UBS &#x7C;Lowers &#x7C;Buy &#x7C; $500.00&#x7C;$565.00 &#x7C; 
&#x7C;Jeffrey Meuler &#x7C;Baird &#x7C;Lowers &#x7C;Outperform &#x7C; $557.00&#x7C;$605.00 &#x7C; 
&#x7C;Jeffrey Meuler &#x7C;Baird &#x7C;Raises &#x7C;Outperform &#x7C; $605.00&#x7C;$579.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Gartner. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Gartner compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Gartner's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Gartner's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/IT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Gartner analyst ratings.</a>
<h2>All You Need to Know About Gartner</h2>
Gartner Inc provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services. The company operates through three business segments, namely Research, Conferences and Consulting. The company generates majority of the revenue from Research segment.
<h3>Understanding the Numbers: Gartner's Finances</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Gartner displayed positive results in 3M. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 8.13%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Gartner's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 23.24%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Gartner's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 32.89%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 4.87%, the company showcases effective utilization of assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.13, caution is advised due to increased financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Beyond The Numbers: 6 Analysts Discuss Gartner Stock

Jones Trading analyst Jason Weaver maintains Dynex Cap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DX#NYSE">DX</a>) with a Buy and lowers the price target from $13.25 to $12.5.

News

Price Target

Jones Trading Maintains Buy on Dynex Cap, Lowers Price Target to $12.5

In the preceding three months, 12 analysts have released ratings for State Street (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>), presenting a wide array of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">7</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for State Street, presenting an average target of $108.42, a high estimate of $139.00, and a low estimate of $85.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 6.06%. 
<img src="https://www.benzinga.com/files/images/story/2025/1745272854_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive State Street. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;David Konrad &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Outperform &#x7C; $113.00&#x7C;$118.00 &#x7C; 
&#x7C;David Smith &#x7C;Truist Securities &#x7C;Lowers &#x7C;Hold &#x7C; $85.00&#x7C;$89.00 &#x7C; 
&#x7C;Jason Goldberg &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $120.00&#x7C;$127.00 &#x7C; 
&#x7C;Betsy Graseck &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Overweight &#x7C; $102.00&#x7C;$132.00 &#x7C; 
&#x7C;David Smith &#x7C;Truist Securities &#x7C;Lowers &#x7C;Hold &#x7C; $89.00&#x7C;$104.00 &#x7C; 
&#x7C;Connor Lynagh &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Overweight &#x7C; $132.00&#x7C;$139.00 &#x7C; 
&#x7C;Ebrahim Poonawala &#x7C;B of A Securities &#x7C;Raises &#x7C;Underperform &#x7C; $99.00&#x7C;$98.00 &#x7C; 
&#x7C;Glenn Schorr &#x7C;Evercore ISI Group &#x7C;Lowers &#x7C;Outperform &#x7C; $106.00&#x7C;$109.00 &#x7C; 
&#x7C;Mike Mayo &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $113.00&#x7C;$118.00 &#x7C; 
&#x7C;Keith Horowitz &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $100.00&#x7C;$105.00 &#x7C; 
&#x7C;Connor Lynagh &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Overweight &#x7C; $139.00&#x7C;$142.00 &#x7C; 
&#x7C;Brian Bedell &#x7C;Deutsche Bank &#x7C;Lowers &#x7C;Hold &#x7C; $103.00&#x7C;$104.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to State Street. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of State Street compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of State Street's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/STT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on State Street analyst ratings.</a>
<h2>Get to Know State Street Better</h2>
State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $47 trillion in assets under custody and administration and $4.7 trillion assets under management as of Dec. 31, 2024, State Street operates globally in more than 100 geographic markets and employs about 53,000 worldwide.
<h3>Financial Milestones: State Street's Journey</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Negative Revenue Trend: Examining State Street's financials over 3M reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -3.75% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: State Street's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 18.18%, the company may face hurdles in effective cost management.
Return on Equity (ROE): State Street's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.62%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): State Street's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.16%, the company may face hurdles in achieving optimal financial performance.
Debt Management: State Street's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.59, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>What Are Analyst Ratings?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 12 Analysts Discuss State Street Stock

In the latest quarter, 10 analysts provided ratings for CarMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated CarMax and provided 12-month price targets. The average target is $90.3, accompanied by a high estimate of $105.00 and a low estimate of $65.00. A 5.54% drop is evident in the current average compared to the previous average price target of $95.60. 
<img src="https://www.benzinga.com/files/images/story/2025/1745272845_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive CarMax. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Seth Basham &#x7C;Wedbush &#x7C;Maintains &#x7C;Outperform &#x7C; $90.00&#x7C;$90.00 &#x7C; 
&#x7C;Seth Basham &#x7C;Wedbush &#x7C;Maintains &#x7C;Outperform &#x7C; $90.00&#x7C;$90.00 &#x7C; 
&#x7C;Steven Shemesh &#x7C;RBC Capital &#x7C;Lowers &#x7C;Outperform &#x7C; $80.00&#x7C;$103.00 &#x7C; 
&#x7C;Seth Basham &#x7C;Wedbush &#x7C;Lowers &#x7C;Outperform &#x7C; $90.00&#x7C;$100.00 &#x7C; 
&#x7C;Craig Kennison &#x7C;Baird &#x7C;Lowers &#x7C;Outperform &#x7C; $90.00&#x7C;$95.00 &#x7C; 
&#x7C;Chris Pierce &#x7C;Needham &#x7C;Lowers &#x7C;Buy &#x7C; $92.00&#x7C;$101.00 &#x7C; 
&#x7C;Seth Basham &#x7C;Wedbush &#x7C;Maintains &#x7C;Outperform &#x7C; $100.00&#x7C;$100.00 &#x7C; 
&#x7C;Rajat Gupta &#x7C;JP Morgan &#x7C;Lowers &#x7C;Underweight &#x7C; $65.00&#x7C;$72.00 &#x7C; 
&#x7C;Michael Montani &#x7C;Evercore ISI Group &#x7C;Lowers &#x7C;Outperform &#x7C; $105.00&#x7C;$107.00 &#x7C; 
&#x7C;Chris Pierce &#x7C;Needham &#x7C;Raises &#x7C;Buy &#x7C; $101.00&#x7C;$98.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CarMax. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of CarMax compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of CarMax's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into CarMax's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/KMX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on CarMax analyst ratings.</a>
<h2>Delving into CarMax's Background</h2>
CarMax sells, finances, and services used and new cars through a chain of around 250 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales were 83% of fiscal 2025 revenue and wholesale about 17%, with the remaining portion composed of extended service plans and repair. In fiscal 2025, the company retailed and wholesaled 789,050 and 544,312 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the US but still estimates that it had only about 3.7% US market share of vehicles 0-10 years old in calendar 2024. It seeks over 5% share. CarMax is based in Richmond, Virginia.
<h3>Key Indicators: CarMax's Financial Health</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Positive Revenue Trend: Examining CarMax's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 6.69% as of 28 February, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: CarMax's net margin is impressive, surpassing industry averages. With a net margin of 1.5%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): CarMax's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.44% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): CarMax's ROA stands out, surpassing industry averages. With an impressive ROA of 0.33%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: CarMax's debt-to-equity ratio is below the industry average at 3.08, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: CarMax Through The Eyes Of 10 Analysts

6 analysts have expressed a variety of opinions on Rexford Industrial Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REXR#NYSE">REXR</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $42.5, with a high estimate of $47.00 and a low estimate of $38.00. Highlighting a 6.24% decrease, the current average has fallen from the previous average price target of $45.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1745272838_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Rexford Industrial Realty. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Samir Khanal &#x7C;Evercore ISI Group &#x7C;Lowers &#x7C;Outperform &#x7C; $40.00&#x7C;$43.00 &#x7C; 
&#x7C;Greg McGinniss &#x7C;Scotiabank &#x7C;Lowers &#x7C;Sector Perform &#x7C; $39.00&#x7C;$47.00 &#x7C; 
&#x7C;Brendan Lynch &#x7C;Barclays &#x7C;Lowers &#x7C;Underweight &#x7C; $38.00&#x7C;$41.00 &#x7C; 
&#x7C;David Rodgers &#x7C;Baird &#x7C;Lowers &#x7C;Neutral &#x7C; $47.00&#x7C;$48.00 &#x7C; 
&#x7C;Greg McGinniss &#x7C;Scotiabank &#x7C;Lowers &#x7C;Sector Perform &#x7C; $47.00&#x7C;$48.00 &#x7C; 
&#x7C;Michael Mueller &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $44.00&#x7C;$45.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Rexford Industrial Realty. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Rexford Industrial Realty compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Rexford Industrial Realty's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Rexford Industrial Realty's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/REXR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Rexford Industrial Realty analyst ratings.</a>
<h2>Discovering Rexford Industrial Realty: A Closer Look</h2>
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.
<h3>Financial Insights: Rexford Industrial Realty</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Rexford Industrial Realty's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 3.87%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Rexford Industrial Realty's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 27.09%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Rexford Industrial Realty's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 0.81%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.53%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.39, Rexford Industrial Realty adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

REXR

What 6 Analyst Ratings Have To Say About Rexford Industrial Realty

Across the recent three months, 5 analysts have shared their insights on New Oriental Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $48.8, along with a high estimate of $52.00 and a low estimate of $44.00. This current average represents a 35.79% decrease from the previous average price target of $76.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1745272831_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of New Oriental Education among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;DS Kim &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $48.00&#x7C;$50.00 &#x7C; 
&#x7C;Michelle Fang &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $50.00&#x7C;$83.00 &#x7C; 
&#x7C;Eddy Wang &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $52.00&#x7C;$83.00 &#x7C; 
&#x7C;Linda Huang &#x7C;Macquarie &#x7C;Lowers &#x7C;Underperform &#x7C; $44.00&#x7C;$79.00 &#x7C; 
&#x7C;DS Kim &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $50.00&#x7C;$85.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to New Oriental Education. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of New Oriental Education compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of New Oriental Education's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of New Oriental Education's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/EDU/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on New Oriental Education analyst ratings.</a>
<h2>Discovering New Oriental Education: A Closer Look</h2>
New Oriental is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation, consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in the livestreaming e-commerce market.
<h3>New Oriental Education: Financial Performance Dissected</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: New Oriental Education's remarkable performance in 3M is evident. As of 30 November, 2024, the company achieved an impressive revenue growth rate of 19.44%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: New Oriental Education's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 3.07%, the company may face hurdles in effective cost management.
Return on Equity (ROE): New Oriental Education's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 0.83%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): New Oriental Education's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.42%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: New Oriental Education's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.2.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

New Oriental Education & Technology Group

What 5 Analyst Ratings Have To Say About New Oriental Education

In the current session, Donaldson Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCI#NYSE">DCI</a>) is trading at $61.70, after a 1.66% decrease. Over the past month, the stock decreased by 9.65%, and in the past year, by 14.83%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1745272822_0.png" alt="Past Year Chart" />

<h3>Comparing Donaldson P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 25.15 in the Machinery industry, Donaldson Inc. has a lower P/E ratio of 18.35. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1745272822_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: Donaldson

In the latest quarter, 6 analysts provided ratings for LKQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKQ#NASDAQ">LKQ</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $56.17, along with a high estimate of $60.00 and a low estimate of $48.00. Highlighting a 0.28% decrease, the current average has fallen from the previous average price target of $56.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1745272820_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive LKQ. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Gary Prestopino &#x7C;Barrington Research &#x7C;Maintains &#x7C;Outperform &#x7C; $60.00&#x7C;$60.00 &#x7C; 
&#x7C;Gary Prestopino &#x7C;Barrington Research &#x7C;Maintains &#x7C;Outperform &#x7C; $60.00&#x7C;$60.00 &#x7C; 
&#x7C;Samik Chatterjee &#x7C;JP Morgan &#x7C;Raises &#x7C;Overweight &#x7C; $49.00&#x7C;$48.00 &#x7C; 
&#x7C;Gary Prestopino &#x7C;Barrington Research &#x7C;Maintains &#x7C;Outperform &#x7C; $60.00&#x7C;$60.00 &#x7C; 
&#x7C;Gary Prestopino &#x7C;Barrington Research &#x7C;Maintains &#x7C;Outperform &#x7C; $60.00&#x7C;$60.00 &#x7C; 
&#x7C;Samik Chatterjee &#x7C;JP Morgan &#x7C;Lowers &#x7C;Overweight &#x7C; $48.00&#x7C;$50.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to LKQ. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of LKQ compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of LKQ's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/LKQ/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on LKQ analyst ratings.</a>
<h2>Delving into LKQ's Background</h2>
Since forming in 1998 to consolidate the auto salvage business in the United States, LKQ has developed into a leading distributor of aftermarket and recycled auto parts with around 1,500 facilities across North America and Europe. The company primarily sells into the professional channel and offers an assortment of collision and mechanical parts to both body shops and mechanical repair shops. It also continues to operate more than 70 LKQ pick-your-part junkyards. Separate from the self-service business, LKQ typically purchases around 250,000 salvage vehicles annually that are used to extract vehicle parts for resale.
<h3>Unraveling the Financial Story of LKQ</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Negative Revenue Trend: Examining LKQ's financials over 3M reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately -4.11% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 4.65%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): LKQ's ROE stands out, surpassing industry averages. With an impressive ROE of 2.55%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.03%, the company showcases effective utilization of assets.
Debt Management: LKQ's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.93.
<h2>What Are Analyst Ratings?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On LKQ Through 6 Analysts

Carpenter Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>) has outperformed the market over the past 20 years by 1.79% on an annualized basis producing an average annual return of 9.6%. Currently, Carpenter Tech has a market capitalization of $8.37 billion. 
Buying $100 In CRS: If an investor had bought $100 of CRS stock 20 years ago, it would be worth $601.04 today based on a price of $167.60 for CRS at the time of writing.
<h3>Carpenter Tech's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745272817_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $100 Invested In Carpenter Tech 20 Years Ago Would Be Worth Today

Barrington Research analyst Gary Prestopino maintains Snap-on (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNA#NYSE">SNA</a>) with a Outperform and maintains $350 price target.

Barrington Research Maintains Outperform on Snap-on, Maintains $350 Price Target

Mueller Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLI#NYSE">MLI</a>) has outperformed the market over the past 5 years by 28.78% on an annualized basis producing an average annual return of 41.46%. Currently, Mueller Industries has a market capitalization of $7.58 billion. 
Buying $100 In MLI: If an investor had bought $100 of MLI stock 5 years ago, it would be worth $562.22 today based on a price of $68.45 for MLI at the time of writing.
<h3>Mueller Industries's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745271918_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

Zions Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) and Western Alliance Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) shares are trading lower in Monday&#8217;s after-hours session after the pair of regional banks reported financial results<a href="https://www.benzinga.com/pressreleases/25/04/n44910623/zions-bancorporation-national-association-reports-first-quarter-financial-results"> for the first quarter</a>.
Here&#8217;s a look at the headline numbers and key commentary from the reports.
ZION Q1 Earnings: Zions Bancorp reported first-quarter revenue of $795 million, missing analyst estimates of $797.07 million, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The bank reported first-quarter earnings of $1.13 per share, missing analyst estimates of $1.17 per share.
&#8220;Credit quality remained in very good shape during the quarter, with nonperforming assets stable compared with last quarter at&nbsp;0.51%&nbsp;of loans and leases and annualized net charge-offs of&nbsp;0.11%&nbsp;of loans and leases. At the same time, the&nbsp;outlook&nbsp;for the economy is perhaps more uncertain than it&#8217;s been in a number of years, clouded by the very real potential for negative impacts from tariffs and trade policy, both here and abroad,&#8221; said Harris Simmons, chairman and CEO of Zions Bancorp.
&#8220;We are nevertheless confident that our credit culture and practices and our strong reserves position us to manage through possible turbulence that might materialize in coming quarters.&#8221;
Zions Bancorp shares were down 3.71% after-hours, trading at $42.41 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. Zions&#8217; shares are down approximately 20% year-to-date.
WAL Q1 Earnings: Western Alliance reported first-quarter net revenue of $778 million, which appears to have come up short of <a href="https://www.benzinga.com/quote/WAL/earnings">analyst estimates</a>. The bank reported first-quarter earnings of $1.79 per share, beating estimates of $1.78 per share, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
&#8220;Western Alliance delivered solid&nbsp;first quarter&nbsp;results led by continued loan and deposit growth following the completion of our balance sheet repositioning efforts in 2024. Our deep segment and product expertise enables our business to adapt quickly to an evolving macro environment, while our fortified capital and liquidity levels position the firm to maintain business momentum and prudent credit risk management,&#8221; said Kenneth Vecchione, president and CEO of Western Alliance.
Western Alliance shares were moving lower, but faring better than Zions Bancorp shares at last check. The stock was down 1.36% after-hours, trading at $64 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44894658/deutsche-bank-standard-chartered-reportedly-looking-into-expanding-to-us-crypto-market">Deutsche Bank, Standard Chartered Reportedly Looking Into Expanding To US Crypto Market</a></li>
</ul>
<ul>
<li><a href="https://www.benzinga.com/etfs/currency-etfs/25/04/44903051/currency-volatility-spikes-as-central-banks-ponder-further-rate-cuts">Currency Volatility Spikes As Central Banks Ponder Further Rate Cuts</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/OLOZANO">OLOZANO</a>/Shutterstock.

Earnings

After-Hours Center

Movers

ZION

Regional Banks Zions, Western Alliance Move Lower Following Q1 Earnings: Key Highlights

Globus Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) has outperformed the market over the past 10 years by 1.42% on an annualized basis producing an average annual return of 10.71%. Currently, Globus Medical has a market capitalization of $9.77 billion. 
Buying $1000 In GMED: If an investor had bought $1000 of GMED stock 10 years ago, it would be worth $2,782.28 today based on a price of $71.01 for GMED at the time of writing.
<h3>Globus Medical's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745271027_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GMED

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

General

VSME

VS Media Holdings Files For Offering Of Minimum $5M To Maximum $15M Of Class A Shares

PFIS

Peoples Financial Services Files For Mixed Shelf Offering Of Up To $150M

Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) has outperformed the market over the past 5 years by 36.18% on an annualized basis producing an average annual return of 48.86%. Currently, Sprouts Farmers Market has a market capitalization of $15.53 billion. 
Buying $1000 In SFM: If an investor had bought $1000 of SFM stock 5 years ago, it would be worth $7,407.94 today based on a price of $157.50 for SFM at the time of writing.
<h3>Sprouts Farmers Market's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745270110_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Sprouts Farmers Market Stock In The Last 5 Years

Wintrust Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTFC#NASDAQ">WTFC</a>) reported quarterly earnings of $2.69 per share which beat the analyst consensus estimate of $2.49 by 8.03 percent. This is a 6.92 percent decrease over earnings of $2.89 per share from the same period last year.

Earnings Beats

WTFC

Wintrust Finl Q1 EPS $2.69 Beats $2.49 Estimate

Guidance

ATKR

Atkore Sees Q2 2025 Adj. EPS $2.01-$2.08 Vs $1.40 Est.; Revenue $695M-$705M Vs $690.83M Est.; Maintains FY25 Adj. EPS Guidance Of $5.75-$6.85 Vs $6.09 Est.; Revenue $2.85B-$2.95B Vs $2.852B Est

<h3>Gainers</h3>
<ul>
<li>Hall Of Fame Resort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOFV#NASDAQ">HOFV</a>) shares rose 23.3% to $0.95 during Monday's after-market session. The company's market cap stands at $6.2 million. </li>
<li>Wag Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) stock rose 8.45% to $0.1. The company's market cap stands at $5.0 million. </li>
<li>Birks Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BGI#AMEX">BGI</a>) stock rose 6.87% to $0.95. The market value of their outstanding shares is at $18.2 million. </li>
<li>Big 5 Sporting Goods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGFV#NASDAQ">BGFV</a>) stock moved upwards by 4.99% to $0.86. The market value of their outstanding shares is at $19.5 million. </li>
<li>Duluth Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTH#NASDAQ">DLTH</a>) stock moved upwards by 4.97% to $1.9. The market value of their outstanding shares is at $68.3 million. </li>
<li>Flexsteel Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLXS#NASDAQ">FLXS</a>) shares rose 4.8% to $33.47. The market value of their outstanding shares is at $176.3 million. The company's, Q3 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>MKDWell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKDW#NASDAQ">MKDW</a>) stock declined by 35.5% to $0.25 during Monday's after-market session. The company's market cap stands at $36.0 million. </li>
<li>ECD Automotive Design (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECDA#NASDAQ">ECDA</a>) stock fell 17.43% to $0.34. The company's market cap stands at $11.9 million. The company's, Q4 earnings came out 4 days ago. </li>
<li>EZGO Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZGO#NASDAQ">EZGO</a>) stock decreased by 11.39% to $0.32. The market value of their outstanding shares is at $1.8 million. </li>
<li>Ruanyun Edai Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYET#NASDAQ">RYET</a>) stock fell 6.85% to $6.94. The market value of their outstanding shares is at $234.2 million. </li>
<li>Lixiang Education Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEH#NASDAQ">LXEH</a>) shares decreased by 5.93% to $2.7. The market value of their outstanding shares is at $3.1 million. </li>
<li>Color Star Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) stock fell 5.43% to $0.74. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BGFV

DLTH

ECDA

EZGO

FLXS

HOFV

LXEH

MKDW

RYET

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) shares increased by 23.5% to $1.26 during Monday's after-market session. The company's market cap stands at $17.3 million. </li>
<li>Beyond Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) stock increased by 21.05% to $0.28. The company's market cap stands at $24.7 million. </li>
<li>Annovis Bio (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANVS#NYSE">ANVS</a>) shares moved upwards by 8.08% to $1.46. The company's market cap stands at $28.4 million. </li>
<li>Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) shares rose 7.65% to $0.23. The company's market cap stands at $1.6 million. </li>
<li>Adial Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADIL#NASDAQ">ADIL</a>) shares increased by 7.63% to $0.72. The market value of their outstanding shares is at $4.7 million. </li>
<li>cbdMD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares rose 7.03% to $0.24. The company's market cap stands at $1.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) shares declined by 15.7% to $3.49 during Monday's after-market session. The company's market cap stands at $53.1 million. </li>
<li>ZyVersa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVSA#NASDAQ">ZVSA</a>) shares decreased by 11.42% to $0.62. The company's market cap stands at $1.5 million. </li>
<li>Medpace Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) stock decreased by 10.04% to $260.0. The market value of their outstanding shares is at $7.9 billion. The company's, Q1 earnings came out today. </li>
<li>Precipio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPO#NASDAQ">PRPO</a>) shares fell 9.19% to $5.24. The market value of their outstanding shares is at $7.7 million. </li>
<li>Enveric Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) shares declined by 7.57% to $1.1. The company's market cap stands at $2.7 million. </li>
<li>Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) shares declined by 6.8% to $0.41. The market value of their outstanding shares is at $13.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Addex Therapeutics

Notizie

Ultime notizie per Addex Therapeutics (NASDAQ:ADXN) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO